Seminars in Nuclear Medicine
Volume 39, Issue 6 , Pages 380-395 , November 2009

Patterns, Variants, Artifacts, and Pitfalls in Conventional Radionuclide Bone Imaging and SPECT/CT

  • Gopinath Gnanasegaran, MD

      Affiliations

    • Department of Nuclear Medicine, Guy's and St Thomas' Hospital, NHS Foundation Trust, London, United Kingdom
    • Corresponding Author InformationAddress reprint requests to Gopinath Gnanasegaran, MD, Department of Nuclear Medicine, St Thomas' Hospital, Guy's and St Thomas' Hospital NHS Foundation Trust, Lambeth Palace Road, London SE1 7EH, United Kingdom
    • ,
  • Gary Cook, MD, FRCR

      Affiliations

    • Department of Nuclear Medicine and PET, The Royal Marsden Hospital NHS Foundation Trust, Surrey, United Kingdom
    • ,
  • Kathryn Adamson, MSc

      Affiliations

    • Department of Nuclear Medicine, Guy's and St Thomas' Hospital, NHS Foundation Trust, London, United Kingdom
    • ,
  • Ignac Fogelman, MD

      Affiliations

    • Department of Nuclear Medicine, Guy's and St Thomas' Hospital, NHS Foundation Trust, London, United Kingdom

References 

  1. Gnanasegaran G, Cook GJ, Fogelman I. Musculoskeletal system. In:  Biersack HJ,  Freeman LM editor. Nuclear Medicine Concise. New York: Springer; 2007;
  2. O'Connor MK, Brown ML, Hung JC, et al. The art of bone scintigraphy: Technical aspects. J Nucl Med. 1991;32:2332–2341
  3. Storey G, Murray IPC. Bone scintigraphy: The procedure and interpretation. In:  Ell PJ,  Gambhir SS editor. Nuclear Medicine in Clinical Diagnosis and Treatment. Vol I:Churchill Livingstone: Elsevier; 2004;p. 593–622New York
  4. Cook GJ, Fogelman I. The role of nuclear medicine in monitoring treatment in skeletal malignancy. Semin Nucl Med. 2001;31:206–211
  5. Cook GJ, Fogelman I. Skeletal metastases from breast cancer: Imaging with nuclear medicine. Semin Nucl Med. 1999;29:69–79
  6. O'Sullivan JM, Cook GJ. A review of the efficacy of bone scanning in prostate and breast cancer. Q J Nucl Med. 2002;46:152–159
  7. Love C, Din AS, Tomas MB, et al. Radionuclide bone imaging: An illustrative review. Radiographics. 2003;23:341–358
  8. Baxter AD, Coakley FV, Finlay DB, et al. The aetiology of solitary hot spots in the ribs on planar bone scans. Nucl Med Commun. 1995;16:834–837
  9. Tumeh SS, Beadle G, Kaplan WD. Clinical significance of solitary rib lesions in patients with extraskeletal malignancy. J Nucl Med. 1985;26:1140–1143
  10. Tofe AJ, Francis MD, Harvey WJ. Correlation of neoplasms with incidence and localisation of skeletal metastases (An analysis of 1355 diphosphonate bone scans). J Nucl Med. 1975;16:986–989
  11. Gates GF, Dore EK. Detection of craniosynostosis by bone scanning. Radiology. 1975;115:665–671
  12. Paterson DC. Myositis ossificans circumscripta: Report of four cases without history of injury. Bone Joint Surg J Br. 1970;52:296–301
  13. Harbert J, Desai R. Small calvarial bone scan foci—Normal variations. J Nucl Med. 1985;26:1144–1148
  14. Senda K, Itoh S. Evaluation of diffusely high uptake by the Calvaria in bone scintigraphy. Ann Nucl Med. 1987;1:23–26
  15. Rao BK, Lieberman LM. Parietal thinning: A cause for photopenia on bone scan. Clin Nucl Med. 1980;5:313
  16. Fink-Bennett DM, Shapiro EE. The Angle of Louis (A potential pitfall (“Louie's Hot Spot”) in bone scan interpretation). Clin Nucl Med. 1984;9:352–354
  17. Fogelman I, Maisey M. An Atlas of Clinical Nuclear Medicine. (ed 1). London: Dunitz Ltd; 1988;
  18. Kwai AH, Stomper PC, Kaplan WD. Clinical significance of isolated scintigraphic sternal lesions in patients with breast cancer. J Nucl Med. 1988;29:324–328
  19. McCormick WFSternal. Foramena in man. Am J Forensic Med Pathol. 1981;2:249–252
  20. Delpassand ES, Garcia JR, Bhadkamkar V, et al. Value of SPECT imaging of the thoracolumbar spine in cancer patients. Clin Nucl Med. 1995;20:1047–1051
  21. Bushnell DL, Kahn D, Huston B, et al. Utility of SPECT imaging for determination of vertebral metastases in patients with known primary tumors. Skeletal Radiol. 1995;24:13–16
  22. Han LJ, Au-Yong TK, Tong WCM, et al. Comparison of bone SPECT and planar imaging in the detection of vertebral metastases in patients with back pain. Eur J Nucl Med. 1998;25:635–638
  23. Coakley FV, Jones AR, Finlay DB, et al. The aetiology and distinguishing features of solitary spinal hot spots on planar bone scans. Clin Radiol. 1995;50:327–330
  24. Fogelman I, McKillop JH, Gray HW. The “hot patella” sign: Is it of any clinical significance? (Concise communication). J Nucl Med. 1983;24:312–315
  25. Kipper MS, Alazraki NP, Feiglin DH. The “hot” patella. Clin Nucl Med. 1982;7:28–32
  26. D'Sa S, Abildgaard N, Tighe J, et al. Guidelines for the use of imaging in the management of myeloma. Br J Haematol. 2007;137:49–63
  27. Johns WD, Garrick MB, Kaplan WD. Leuprolide therapy for prostate cancer (An association with scintigraphic flare on bone scan). Clin Nucl Med. 1990;15:485–487
  28. Haywood JL, Carbone PP, Heuson JC, et al. Assessment of response to therapy in advanced breast cancer. Eur J Cancer. 1977;13:89–94
  29. Citrin DL. Problems and limitations of bone scanning with Tc99m phosphates. Clin Radiol. 1977;28:97–105
  30. Schneider JA, Divgi CR, Scott AM, et al. Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer. J Nucl Med. 1994;35:1748–1752
  31. Loutfi I, Collier BD, Mohammed AM. Nonosseous abnormalities on bone scans. J Nucl Med Technol. 2003;31:149–153
  32. Kaye J, Hayward M. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: Pictorial review. Australas Radiol. 2002;46:13–21
  33. Gentili A, Miron SD, Bellon EM. Nonosseous accumulation of bone-seeking radiopharmaceuticals. Radiographics. 1990;10:871–881
  34. Gentili A, Miron SD, Adler LP. Review of some common artifacts in nuclear medicine. Clin Nucl Med. 1994;19:138–143
  35. McAfee JC, Singh A, Roskopf M, et al. Experimental drug-induced changes in renal function and biodistribution of Tc99m MDP. Invest Radiol. 1983;18:470–478
  36. Hung JC, Ponto JA, Hammes RJ. Radiopharmaceutical-related pitfalls and artifacts. Semin Nucl Med. 1996;26:208–255
  37. Wilson MA, Pollack MJ. Gastric visualization and image quality in radionuclide bone scanning: Concise communication. J Nucl Med. 1981;22:518–521
  38. Chaudhuri TK. The effect of aluminum and pH on altered body distribution of Tc99m EHDP. Int J Nucl Med Biol. 1976;3:37
  39. Al-Enizi E, Kazem N, Owunwanne A, et al. Dextrose solutions yield radiopharmaceutical impurities: The “sweet” scans. J Nucl Med Technol. 2003;31:33–36
  40. Kessler JR, Wells RG, Sty JR. Skeletal scintigraphy: Radiographic artifacts. Clin Nucl Med. 1992;17:511–512
  41. Dogan A, Rezai K. Incidental lymph node visualisation on bone scan due to subcutaneous infiltration of Tc99m MDP. Clin Nucl Med. 1993;18:208–209
  42. O'Connor MK, Kelly BJ. Evaluation of techniques for the elimination of Hot” bladder artifacts in SPECT of the pelvis. J Nucl Med. 1990;31:1872–1875
  43. Bunker SR, Handmaker H, Torre DM, et al. Pixel overflow artifacts in SPECT evaluation of the skeleton. Radiology. 1990;174:229–232
  44. Ogawa K. Image distortion and correction in single photon emission CT. Ann Nucl Med. 2004;18:171–185
  45. O'Connor MK. Instrument- and computer-related problems and artifacts in nuclear medicine. Semin Nucl Med. 1996;26:256–277
  46. Forstrom LA, Dunn WL, O'Connor MK, et al. Technical pitfalls in image acquisition, processing, and display. Semin Nucl Med. 1996;26:278–294
  47. Howarth DM, Forstrom LA, O'Connor MK, et al. Patient-related pitfalls and artifacts in nuclear medicine imaging. Semin Nucl Med. 1996;26:295–307
  48. Kalendar WA. Computed Tomography. (ed 2). Erlangen, Germany: Publicis Corporate Publishing; 2005;
  49. Popilock R, Sandrasagaren K, Harris L, et al. Artifact recognition for the nuclear technologist. J Nucl Med Technol. 2008;36:79–81
  50. Barrett JF, Keat N. Artefacts in CT: Recognition and avoidance. Radiographics. 2004;24:1679–1691
  51. Wilting JE, Timmer J. Artefacts in spiral-CT images and their relation to pitch and subject morphology. Eur Radiol. 1999;9:316–322
  52. Fleischmann D, Rubin GD, Paik DS, et al. Stair-step artifacts with single versus multiple detector-row helical CT. Radiology. 2000;216:185–196
  53. Silver MD, Taguchi K, Hein IA, et al. Windmill artefact in multislice CT. Proc SPIE. 2003;5032:1918–1927
  54. Zimmer AM, Isitman AT, Holmes RA. Enzymatic inhibition of diphosphonate: A proposed mechanism of tissue uptake. J Nucl Med. 1975;16:352–356
  55. Peller P, Ho V, Kransdorf M. Extraosseous Tc99m MDP uptake: A pathophysiological approach. Radiographics. 1993;13:715–734
  56. Duong R, Volarich D, Fernandez-Ulloa M, et al. Tc99m MDP bone scan artefact: Abdominal soft tissue uptake secondary to subcutaneous heparin injection. Clin Nucl Med. 1984;9:47
  57. Nizami MA, Gerntholtz T, Swanepoel CR. The role of bone scanning in the detection of metastatic calcification: A case report. Clin Nucl Med. 2000;25:407–409
  58. Low RD, Hicks RJ, Gill G, et al. Tc99m MDP uptake in a cerebral infarct. Clin Nucl Med. 1992;17:968–970
  59. Padhy AK, Gopinath PG, Amini AC. Myocardial, pulmonary, diaphragmatic, gastric, splenic, and renal uptake oft c-99m MDP in patients with persistent, severe hypercalcemia. Clin Nucleus Med. 1990;15:648–649
  60. Coolens J, Devos P, De Roo M. Diffuse pulmonary uptake of Tc99m bone imaging agents: Case report and survey. Eur J Nucl Med. 1985;11:36–42
  61. Maloof J, Hurst J, Gupta N. Diffuse pulmonary uptake of Tc99m MDP in sarcoidosis. Clin Nucl Med. 1996;21:77–79
  62. Siegel ME, Walker WJ, Campbell JL. Accumulation of 99mTc-diphosphonate in malignant pleural effusions. J Nucl Med. 1975;16:883–885
  63. Vanhecke W, Merckx E, De Roo M, et al. Soft tissue uptake on Tc99m MDP bone scan after cardioversion. Clin Nucl Med. 1989;14:923
  64. Lee VW, Caldarone AG, Falk RH, et al. Amyloidosis of heart and liver: Comparison of Tc99m pyrophosphate and Tc99m methylene diphosphonate for detection. Radiology. 1983;148:239–242
  65. Atkins HL, Oster ZH. Myocardial uptake of a bone tracer associated with hypercalcemia. Clin Nucl Med. 1984;9:613–615
  66. Ali A, Turner DA, Rosenbush SW, et al. Bone scintigram in cardiac amyloidosis: A case report. Clin Nucl Med. 1981;6:105–108
  67. Piccolo S, Lastoria S, Mainolfi C, et al. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med. 1995;36:718–724
  68. Swayne LC. Bone imaging in unusually massive breast carcinoma with chest wall invasion. Clin Nucl Med. 1991;16:593–594
  69. Harvey JA, Fondriest JE, Smith MM. Densely calcified breast mass. Invest Radiol. 1994;29:516–518
  70. Vieras F, Boyd CM. Diagnostic value of renal imaging incidental to bone scintigraphy with Tc99m phosphate compounds. J Nucl Med. 1975;16:1109–1114
  71. Biello DR, Coleman RE, Stanley RJ. Correlation of renal images on bone scan and intravenous pyelogram. AJR Am J Roentgenol. 1976;127:633–636
  72. Wulfeck DW, Sakow NK, Senler S. Detection of recurrent renal cell carcinoma by three-phase bone scan. Clin Nucl Med. 1993;18:441–443
  73. Bernard M, Hayward M, Hayward C. Evaluation of intense renal parenchymal activity (“Hot Kidneys”) on bone scintigraphy. Clin Nucl Med. 1990;15:254–256
  74. Gentili A, Miron SD, Adler LP, et al. Incidental detection of urinary tract abnormalities with skeletal scintigraphy. Radiographics. 1991;11:571–579
  75. Straub WH, Slasky BS. Accumulation of bone scanning agent in a communicating renal cortical cyst. Clin Nucl Med. 1982;7:378
  76. Kim SE, Kim DY, Lee DS, et al. Absent or faint renal uptake on bone scan (Etiology and significance in metastatic bone disease). Clin Nucl Med. 1991;16:545–549
  77. Buxton-Thomas MS, Wraight EP. High renal activity on bone scintigrams: A sign of hypercalcaemia?. Br J Radiol. 1983;56:911–914
  78. Koizumi K, Tonami N, Hisada K. Diffusely increased Tc99m-MDP uptake in both kidneys. Clin Nucl Med. 1981;6:362–365
  79. Lutrin CL, Goris ML. Pyrophosphate retention by previously irradiated renal tissue. Radiology. 1979;133:207–209
  80. Trackler RT, Chinn RYW. Amphotericin B therapy: A cause of increased renal uptake of Tc99m MDP. Clin Nuci Med. 1982;7:293
  81. Sugimura K, Narabayashi I, Yamazaki K, et al. Bone scintigraphic findings in 2 cases of myositis ossificans progressiva. [Kaku Igaku Japanese] J Nucl Med. 1983;20:875–879
  82. Chew FS, Hudson TM, Enneking WF. Radionuclide imaging of soft tissue neoplasms. Semin Nucl Med. 1981;11:266–276
  83. Maurer A, Paczolt E, Myers A. Diagnosis of traumatic myositis intrinsic muscles of the hand by the use of three-phase skeletal scintigraphy. Clin Nucl Med. 1990;15:535–538
  84. Sud A, Wilson M, Mountz J. Unusual clinical presentation and scintigraphic pattern in myositis ossificans. Clin Nucl Med. 1991;17:198–199
  85. Abdel-Dayem H. Tc99m-MDP uptake in rhabdomyolysis. Clin Nucl Med. 1981;6:130
  86. Buchpiguel CA, Roizemblatt S, Pastor EH, et al. Cardiac and skeletal muscle scintigraphy in dermato- and polymyositis: Clinical implications. Eur J Nucl Med. 1996;23:199–203
  87. Pape HC, Lehmann U, van Griensven M, et al. Heterotopic ossifications in patients after severe blunt trauma with and without head trauma: Incidence and patterns of distribution. J Orthop Trauma. 2001;15:229–237
  88. Lafforgue P, Siles S, Daumen-Legre V, et al. An unexpected, benign cause of increased muscular uptake at bone scintigraphy. Clin Exp Rheumatol. 1994;12:309–311
  89. Romyn AM, Bushnell DL, Freeman ML, et al. Visualization of metastatic liver disease on technetium-99m bone scintigraphy. Clin Nucl Med. 1987;12:264–267
  90. Sherkow L, Ryo U, Fabich D, et al. Visualisation of the liver, gallbladder and intestine on bone scintigraphy. Clin Nucl Med. 1984;9:440–443
  91. Adalet I, Kocak M, Oguz H, et al. Incidental visualisation of hepatic hemangiomas during Tc99m (v) DMSA, Tl-201 and Tc99m MDP imaging. Clin Nucl Med. 1995;20:1106–1107
  92. Connolly LP, Bloom DA, Kozakewich H, et al. Localization of Tc99m MDP in neuroblastoma metastases to the liver and lung. Clin Nucl Med. 1996;21:629–633
  93. Silberstein EB, DeLong S, Cline J. Tc99m diphosphonate and sulfur colloid uptake by the spleen in sickle cell disease: Interrelationship and clinical correlates. J Nucl Med. 1984;25:1300–1303
  94. Hansen S, Stadalnik RC. Liver uptake of 99mTc-pyrophosphate. Semin Nucl Med. 1982;12:89–91
  95. Morrison SC, Adler LP. Bone imaging agent uptake with hepatoblastoma. Clin Nucl Med. 1992;17:680
  96. Solanki HP, Chertow BS. Dramatic improvement of soft tissue uptake of liver metastases on bone imaging. Clin Nucl Med. 1994;19:346–347
  97. Dhekne RD. Splenic concentration of bone imaging agents in functional asplenia. Clin Nucl Med. 1981;6:313–317
  98. Dravid VS, Heyman S. Splenic uptake on bone scanning in autoimmune hemolytic anemia. Clin Nucl Med. 1990;15:584
  99. Meyer M, McClaughry P. Reversible Tc99m diphosphonate uptake in gastric tissue associated with malignancy related hypercalcemia. Clin Nucl Med. 1995;20:767–769
  100. Duong R, Volarich D, Fernandez-Ulloa M, et al. Tc99m MDP bone scan artefact: Abdominal soft tissue uptake secondary to subcutaneous heparin injection. Clin Nucl Med. 1984;9:47
  101. Gordon L, Schabel SI, Holland RD, et al. Technetium-99m methylene diphosphonate accumulation in ascitic fluid due to neoplasm. Radiology. 1981;139:699–702
  102. Choy D, Murray IP. Metastatic visceral calcification identified by bone scanning. Skeletal Radiol. 1980;5:151–159
  103. Yang KT, Lin TS. Visualization of a supradiaphragmatic stomach in a patient with esophagogastrectomy who practiced urine therapy during bone scan. Clin Nucl Med. 2001;26:1042
  104. Kosuda S, Katagiri S, Ka WJ, et al. Demonstration of the ascending colon on Tc99m MDP skeletal imaging: Pitfall in bone scanning by a faith cure of drinking urine. Clin Nucl Med. 2000;25:1040–1041
  105. Adams KJ, Shuler SE, Witherspoon LR, et al. A retrospective analysis of renal abnormalities detected on bone scans. Clin Nucl Med. 1980;5:1–7
  106. Reddy PS, Merrick MV. Skeletal scintigraphy in carcinoma of the kidney. Br J Urol. 1983;55:171–173

PII: S0001-2998(09)00057-9

doi: 10.1053/j.semnuclmed.2009.07.003

Seminars in Nuclear Medicine
Volume 39, Issue 6 , Pages 380-395 , November 2009

Article Tools

* Image Usage & Resolution